References
- Rosano G M, Vitale C, Tulli A. Managing cardiovascular risk in menopausal women. Climacteric 2006; 9(Suppl 1)919–927
- Stone P H, Thompson B, Anderson H V, et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI III registry. JAMA 1996; 275: 1104–1112
- Sever P S, Dahlöf B, Poulter N R, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003; 361: 1149–1158
- Rosano G MC, Vitale C, Marazzi G, Volterrani M. Menopause and cardiovascular disease: the evidence. Climacteric 2007; 10(Suppl 1)19–24
- Castelli W P. Cholesterol and lipids in the risk of coronary artery disease – the Framingham Heart Study. Can J Cardiol 1988; 4(Suppl A)5–10A
- European Society of Hypertension–European Society of Cardiology Guidelines Committee. European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–1053
- Shepherd J, Blauw G J, Murphy M B, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 2002; 360: 1623–1630
- Vitale C, Miceli M, Rosano G MC. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention. Climacteric 2007; 10(Suppl 2)16–20
- National Cholesterol Education Program. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 269: 3015–3023
- Guidelines for using serum cholesterol, high-density lipoprotein cholesterol, and triglyceride levels as screening tests for preventing coronary heart disease in adults. American College of Physicians. Part 1. Ann Intern Med 1996; 124: 515–517
- Collins P, Rosano G, Casey C, et al. Management of cardiovascular risk in perimenopausal women: a consensus statement of European cardiologists and gynecologists. Climacteric 2007; 10: 508–526, (Reproduced from Eur Heart J 2007;28:2028–40)
- National Cholesterol Education Program. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in (Adults Treatment Panel III) Final Report. Circulation 2002; 106: 3143–3421
- MRC/BHF Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. Eur Heart J 1999; 20: 725–741
- Nakamura H, Arakawa K, Itakura H, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 2006; 368: 1155–1163
- Sirtori C R, Calabresi L. Japan: are statins still good for everybody. Lancet 2006; 368: 1135–1136